Blue Jet Healthcare Limited — Important, 29-01-2025: Financial Result Updates

**Consolidated Financials**: Blue Jet Healthcare Limited has reported its financial results for the quarter and nine months ending December 31, 2024.

**Revenue Growth**: Total revenue from operations for the quarter stood at ₹318.38 crore, reflecting a significant increase from ₹166.76 crore in the same period last year, marking a growth of approximately 91%. This growth is likely driven by increased demand in the healthcare sector and strategic market expansion efforts.

**Profit and EPS**: The net profit for the quarter reached ₹98.98 crore, compared to ₹32.10 crore in the previous year, showcasing a robust growth trajectory. Earnings Per Share (EPS) has increased to ₹5.71 from ₹1.85, attributed to higher operational efficiencies and lower depreciation expenses due to a change in depreciation method.

**Operational Costs**: Operating expenses have risen, predominantly due to an increase in employee benefits, which amounted to ₹14.82 crore. However, the overall proportionate increase is managed well, showing a commitment to cost control amid expansion.

**Balance Sheet & Cash Flow Statement**: The stability of the balance sheet is evident with a healthy equity base. The company’s other equity totals ₹810.53 crore, providing a strong buffer for future investments. Cash flows remain stable, reinforcing financial resilience.

**Strategic Position and Outlook**: The upcoming investment of ₹40 crore in a Research and Development facility indicates a strategic pivot towards innovation and long-term growth. The positive financial trajectory is likely to enhance investor sentiment and market positioning.

**Investor Insight**: Given the impressive earnings growth, effective cost management, and strategic investments in R&D, there is a strong case for a buy position in Blue Jet Healthcare Limited, with potential for further growth in the coming quarters.